by Dr Gayatri Sharma, CellVec    Singapore has long been a strategic base for a range of businesses and industries seeking to leverage its favourable location and environment for regional growth and expansion. For many, its reliable infrastructure provides additional attractiveness a...

In the next episode of #CellVecConversations, joining us today is Shanmugam Buvaneswaran, our Head of Production who holds decades of manufacturing experience under his belt. Hear Buvanes’ thoughts on what makes a good CDMO and how CellVec is poised to manufacture lentiviral vectors at scale b...

Joining us today for our #CellVecConversations is Dr Lucas Chan, Scientific Founder and Chief Scientific Officer of CellVec. Find out more from the man behind the science that powers CellVec, and his views on the viral vector industry!...

Check out the first episode of #CellVecConversations, where we speak to the team at CellVec to understand how the brand is navigating the exciting industry. Joining us today is Dr. Gayatri Sharma, Chief Commercial Officer of CellVec. Tune in for her journey with CellVec and her perspective on the ce...

Fabio Michelet, Senior Scientist (Viral Vectors)  The hypothesis of using exogenous genetic material as a tool to inactivate or replace disease-causing genes or restore correct cellular function, dates back to the 70s. Since then, scientists have been working to develop a system to efficiently ...

Dr. Paula Lam, Head of Research & Development at CellVec, shared about the efficiency of our GMP-compliant LV manufacturing process at ISCT2021. With high yield, high purity vector stocks, GMP vector products that are highly potent on primary T cells and stable transduction efficiencies, every b...